Related Experiment Videos
Bcl-xL as an antiapoptotic molecule for cardiomyocytes
Yukiyo Ogata1, Masafumi Takahashi
1Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical School, Tochigi, Japan.
Abstract:
It is now widely accepted that two forms of cell death, apoptosis and necrosis, occur in cardiomyocytes, and increasing evidence indicates that apoptosis plays an important role in the pathophysiology of cardiovascular diseases. Currently, two major pathways in the induction of apoptosis are known to occur in cardiomyocytes, the mitochondrial pathway and the death receptor pathway. Bcl-2 family proteins are key regulators of apoptosis in the mitochondrial pathway. Among them, Bcl-x(L), which is structurally similar to Bcl-2 and functions as an antiapoptotic molecule, is involved in diseases such as ischemic heart diseases and heart failure. In this review, we focus on the role of Bcl-x(L) in apoptosis in cardiomyocytes and discuss the potential use of Bcl-x(L) as a cardioprotective therapy for cardiac diseases.
Insights
Apoptosis, a key cell death form in cardiovascular diseases, is regulated by Bcl-2 family proteins like Bcl-x(L). This review explores Bcl-x(L)
Area of Science:
- Cardiovascular Biology
- Cell Death Mechanisms
- Molecular Cardiology
Background:
- Cardiomyocytes undergo apoptosis and necrosis, with apoptosis crucial in cardiovascular disease pathophysiology.
- Apoptosis in cardiomyocytes is induced via mitochondrial and death receptor pathways.
- Bcl-2 family proteins, including Bcl-x(L), are critical regulators of the mitochondrial apoptotic pathway.
Purpose of the Study:
- To review the role of Bcl-x(L) in cardiomyocyte apoptosis.
- To discuss the therapeutic potential of Bcl-x(L) in treating cardiac diseases.
Main Methods:
- Literature review focusing on Bcl-x(L) and cardiomyocyte apoptosis.
- Analysis of existing evidence on Bcl-x(L) function in cardiac pathophysiology.
- Exploration of therapeutic strategies involving Bcl-x(L).
Main Results:
- Bcl-x(L) acts as an antiapoptotic molecule in cardiomyocytes.
- Dysregulation of Bcl-x(L) is implicated in ischemic heart diseases and heart failure.
- Bcl-x(L) has demonstrated potential as a cardioprotective agent.
Conclusions:
- Bcl-x(L) plays a significant role in regulating apoptosis within cardiomyocytes.
- Targeting Bcl-x(L) offers a promising therapeutic avenue for cardiovascular diseases.
- Further research into Bcl-x(L) may lead to novel cardioprotective strategies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway
Apoptosis
Caspases
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...